Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Akamatsu

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|November 2, 2019
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studiesYuki Kita, Akihiro Hamada, Ryoichi Saito, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Cancer Reports (Hoboken, N.J.)|February 22, 2023
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft modelsTakahiro Nagai, Naoki Terada, Masato Fujii, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report]Toshihiro Magaribuchi, Takashi Kobayashi, Naoko Kamo, et al.
Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.
Carcinogenesis|May 7, 2019
Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesisMasayuki Uegaki, Yuki Kita, Ryutaro Shirakawa, et al.
Cancer Science|September 30, 2010
Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibilitySuyoun Chung, Hidewaki Nakagawa, Motohide Uemura, et al.
The Prostate|May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate CancerTakuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 6, 2016
[Deceased Donor Kidney Transplantation from a Liver Transplantation Recipient]Shuhei Koike, Takashi Kobayashi, Yoshiyuki Okada, et al.
International Journal of Clinical Oncology|January 16, 2026
<sup>18</sup>F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatmentShiori Murata, Yusaku Moribata, Shusuke Akamatsu, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|November 2, 2019
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studiesYuki Kita, Akihiro Hamada, Ryoichi Saito, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Cancer Reports (Hoboken, N.J.)|February 22, 2023
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft modelsTakahiro Nagai, Naoki Terada, Masato Fujii, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report]Toshihiro Magaribuchi, Takashi Kobayashi, Naoko Kamo, et al.
Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.
Carcinogenesis|May 7, 2019
Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesisMasayuki Uegaki, Yuki Kita, Ryutaro Shirakawa, et al.
Cancer Science|September 30, 2010
Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibilitySuyoun Chung, Hidewaki Nakagawa, Motohide Uemura, et al.
The Prostate|May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate CancerTakuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 6, 2016
[Deceased Donor Kidney Transplantation from a Liver Transplantation Recipient]Shuhei Koike, Takashi Kobayashi, Yoshiyuki Okada, et al.
International Journal of Clinical Oncology|January 16, 2026
<sup>18</sup>F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatmentShiori Murata, Yusaku Moribata, Shusuke Akamatsu, et al.
Pageof 21